Literature DB >> 22563307

Use of Secondary Data to Estimate Instantaneous Model Parameters of Diabetic Heart Disease: Lemonade Method.

Wen Ye1, Deanna Jm Isaman, Jacob Barhak.   

Abstract

With the increasing burden of chronic diseases on the health care system, Markov-type models are becoming popular to predict the long-term outcomes of early intervention and to guide disease management. However, statisticians have not been actively involved in the development of these models. Typically, the models are developed by using secondary data analysis to find a single "best" study to estimate each transition in the model. However, due to the nature of secondary data analysis, there frequently are discrepancies between the theoretical model and the design of the studies being used. This paper illustrates a likelihood approach to correctly model the design of clinical studies under the conditions where 1) the theoretical model may include an instantaneous state of distinct interest to the researchers, and 2) the study design may be such that study data can not be used to estimate a single parameter in the theoretical model of interest. For example, a study may ignore intermediary stages of disease. Using our approach, not only can we accommodate the two conditions above, but more than one study may be used to estimate model parameters. In the spirit of "If life gives you lemon, make lemonade", we call this method "Lemonade Method". Simulation studies are carried out to evaluate the finite sample property of this method. In addition, the method is demonstrated through application to a model of heart disease in diabetes.

Entities:  

Year:  2010        PMID: 22563307      PMCID: PMC3341173          DOI: 10.1016/j.inffus.2010.08.003

Source DB:  PubMed          Journal:  Inf Fusion        ISSN: 1566-2535            Impact factor:   12.975


  15 in total

Review 1.  Simulation modeling of outcomes and cost effectiveness.

Authors:  S D Ramsey; M McIntosh; R Etzioni; N Urban
Journal:  Hematol Oncol Clin North Am       Date:  2000-08       Impact factor: 3.722

2.  A discrete-state discrete-time model using indirect observation.

Authors:  Deanna J M Isaman; William H Herman; Morton B Brown
Journal:  Stat Med       Date:  2006-03-30       Impact factor: 2.373

3.  A computer simulation model of diabetes progression, quality of life, and cost.

Authors:  Honghong Zhou; Deanna J M Isaman; Shari Messinger; Morton B Brown; Ronald Klein; Michael Brandle; William H Herman
Journal:  Diabetes Care       Date:  2005-12       Impact factor: 19.112

4.  The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56).

Authors:  R J Stevens; V Kothari; A I Adler; I M Stratton
Journal:  Clin Sci (Lond)       Date:  2001-12       Impact factor: 6.124

5.  Chronic disease modeling and simulation software.

Authors:  Jacob Barhak; Deanna J M Isaman; Wen Ye; Donghee Lee
Journal:  J Biomed Inform       Date:  2010-06-15       Impact factor: 6.317

6.  The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment? Results of a population-based myocardial infarction register follow-up study.

Authors:  H Löwel; W Koenig; S Engel; A Hörmann; U Keil
Journal:  Diabetologia       Date:  2000-02       Impact factor: 10.122

7.  Impact of diabetes on mortality after the first myocardial infarction. The FINMONICA Myocardial Infarction Register Study Group.

Authors:  H Miettinen; S Lehto; V Salomaa; M Mähönen; M Niemelä; S M Haffner; K Pyörälä; J Tuomilehto
Journal:  Diabetes Care       Date:  1998-01       Impact factor: 19.112

8.  Long-term prognosis after myocardial infarction in men with diabetes.

Authors:  G Ulvenstam; A Aberg; R Bergstrand; S Johansson; K Pennert; A Vedin; L Wilhelmsen; C Wilhelmsson
Journal:  Diabetes       Date:  1985-08       Impact factor: 9.461

9.  Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

10.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.